ElleVet Sciences has launched its Feline CBD + CBDA Soft Chews, a product designed to support stress, mobility and overall wellbeing in cats.
The company said the chews build on years of feline-focused research, product development and clinical studies, offering cat owners and veterinarians an option specifically formulated for cats' preferences and needs.
ElleVet said it has conducted feline-specific studies over the years, including safety, pharmacokinetic and clinical research, while developing a feline product line to address cats' physiological and behavioral needs.
"Developing products for cats requires a fundamentally different approach," said Christian Kjaer, CEO of ElleVet Sciences. "Cats are notoriously picky, so creating a chew that's both palatable and scientifically effective is a huge step forward. This launch represents our commitment to improving the lives of all pets with products that are trusted by veterinarians, backed by science, and truly effective."
The salmon-flavored soft chews are formulated with ElleVet's CBD + CBDA oil and were developed following palatability testing, informed by the company's earlier feline safety and pharmacokinetic studies to ensure appropriate administration, absorption and long-term tolerability.
The small, triangle-shaped chews expand on existing options like soft gels, pastes and oils.
"Having a palatable option is critical for consistent use, which ultimately drives better outcomes," said Joseph Wakshlag, DVM, PhD, DACVIM (Nutrition), DACVSMR and chief veterinary medical officer at ElleVet Sciences. "Early data and owner feedback show meaningful results in mobility, social behavior, and urinary health, clear signs that cats are feeling more comfortable and engaged. It's incredibly rewarding to see such positive outcomes that truly enhance a cat's quality of life."
The launch follows ElleVet's recently published randomized, double-blinded, placebo-controlled feline mobility clinical trial in The Journal of Feline Medicine and Surgery. The company said the study demonstrated statistically significant enhancements in gait, stair navigation, jumping and play behavior in cats receiving ElleVet's CBD + CBDA formulation, with no notable safety concerns after six weeks of use.
